Advisory Committee on Childhood Lead Poisoning Prevention, 6073-6074 [E6-1557]

Download as PDF rmajette on PROD1PC67 with NOTICES1 Federal Register / Vol. 71, No. 24 / Monday, February 6, 2006 / Notices month since 2002. The Complainant further contends the MPA has demanded that Complainant vacate the premises after refusing to negotiate a commercially reasonable lease. Complainant alleges that the MPA and its Directors have violated Section 10(d)(1) of the Act (46 U.S.C. App. 1709(d)(1)) by failing to establish, observe, and enforce just and reasonable regulations and practices relating to or connected with receiving, handling, storing, or delivering property. In addition, Complainant alleges that Respondents violated Sections 10(d)(3) of the Act (46 USA App. § 1709(d)(3)) by unreasonably refusing to deal with a tenant, and 10(d)(4) of the Act (46 U.S.C. App. 1709(d)(4)) by giving undue or unreasonable preference or advantage or imposing undue or unreasonable prejudice or disadvantage with respect to any person. Respondent asserts that the Commission has found that it might have jurisdiction to adjudicate a ‘‘* * * privately-initiated complaint proceeding against the directors of a state-run port rather than against the port.’’ Respondent prays that the Commission: seek a temporary restraining order and preliminary injunction enjoining the Respondents to cease their unlawful treatment of Complainant and from leasing the lot to another company; declare that the Respondents have violated the Act as detailed above and direct the Respondents to cease all such violations; direct Respondents to offer Complainant a commercially viable lease for the lot in question; award Complainant reparations for actual injuries, pre and post-judgment interest, and litigation and attorney fees; and award such other and further relief as deemed just and proper. This proceeding has been assigned to the Office of Administrative Law Judges. Hearing in this matter, if any is held, shall commence within the time limitations prescribed in 46 CFR 502.61, and only after consideration has been given by the parties and the presiding officer to the use of alternative forms of dispute resolution. The hearing shall include oral testimony and crossexamination in the discretion of the presiding officer only upon proper showing that there are genuine issues of material fact that cannot be resolved on the basis of sworn statements, affidavits, depositions, or other documents or that the nature of the matter in issue is such that an oral hearing and crossexamination are necessary for the development of an adequate record. Pursuant to the further terms of 46 CFR 502.61, the initial decision of the presiding officer in this proceeding shall VerDate Aug<31>2005 14:55 Feb 03, 2006 Jkt 208001 be issued by January 31, 2007, and the final decision of the Commission shall be issued by May 31, 2007. Bryant L. VanBrakle, Secretary. [FR Doc. E6–1589 Filed 2–3–06; 8:45 am] 6073 Dated: January 13, 2006. Felipe Mendoza, Associate Administrator, Office of Small Business Utilization, General Services Administration. [FR Doc. E6–1525 Filed 2–3–06; 8:45 am] BILLING CODE 6820–34–S BILLING CODE 6730–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL SERVICES ADMINISTRATION Office of Small Business Utilization; Small Business Advisory Committee; Notification of a Public Meeting of the Small Business Advisory Committee Office of Small Business Utilization, GSA. ACTION: Notice. AGENCY: SUMMARY: The General Services Administration (GSA) is announcing a public meeting of the GSA Small Business Advisory Committee (the Committee). The meeting will take place February 21–22. The meeting will begin 1 p.m. Tuesday February 21 and conclude no later than 5 p.m. that day. The meeting will resume 9 a.m. Wednesday February 22 and conclude no later than 3 p.m. that day. The Committee will accept oral public comments at this meeting and has reserved a total of sixty minutes for this purpose. Members of the public wishing to reserve speaking time must contact Denis Peck in writing at: denis.peck@gsa.gov or by fax at (202) 208–5938, no later than one week prior to the meeting. ADDRESS: GSA Central Office Auditorium, 1800 F Street, NW., Washington, DC 20405. FOR FURTHER INFORMATION CONTACT: Denis Peck, Room 6021, GSA Building, 1800 F Street, NW., Washington, DC 20405 (202) 501–1021 or e-mail at denis.peck@gsa.gov. DATES: This notice is published in accordance with the provisions of the Federal Advisory Committee Act (FACA) (Pub. L. 92– 463). SUPPLEMENTARY INFORMATION: Background: The purpose of this meeting is to develop the topics generated during the previous meeting September 1, 2005; to receive briefings from small business topical experts, and to hear from interested members of the public on proposals to improve GSA’s small business contracting performance. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the National Center for Environmental Health (NCEH) of the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. Name: Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP). Times and Dates: 8:30 a.m.–5 p.m., March 21, 2006. 8:30 a.m.–12:30 p.m., March 22, 2006. Place: Magnolia Hotel, 1100 Texas Avenue, Houston, Texas 77002. Telephone: (281)657–2664 or toll free 1–888–915–1110. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The committee shall provide advice and guidance to the Secretary, Department of Health and Human Services; the Assistant Secretary for Health; and the Director, CDC, regarding new scientific knowledge and technological developments and their practical implications for childhood lead poisoning prevention efforts. The committee shall also review and report regularly on childhood lead poisoning prevention practices and recommend improvements in national childhood lead poisoning prevention efforts. Matters to be Discussed: Update on the Primary Prevention Workgroup document; update on the Adverse Health Effects of Blood Lead Levels less than 10 Report; update from the Lead and Pregnancy Workgroup; update of strategic planning process by state and local childhood lead poisoning prevention programs; update on cooperation with the U.S. Department of Housing and Urban Development and the U.S. Environmental Protection Agency enforcement of the Lead Disclosure Rule; and an update on research and program evaluation activities ongoing in the Lead Poisoning Prevention Branch. E:\FR\FM\06FEN1.SGM 06FEN1 6074 Federal Register / Vol. 71, No. 24 / Monday, February 6, 2006 / Notices Agenda items are subject to change as priorities dictate. Opportunities will be provided during the meeting for oral comments. Depending on the time available and the number of requests, it may be necessary to limit the time of each presenter. Contact Person For More Information: Claudine Johnson, Lead Poisoning Prevention Branch, Division of Emergency and Environmental Health Services, NCEH, CDC, 4770 Buford Hwy, NE., M/S F–40, Atlanta, Georgia 30341, telephone (770) 488–3629, fax (770) 488–3625. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: January 30, 2006. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–1557 Filed 2–3–06; 8:45 am] Adolescent health; (7) Provider reminders and provider incentives for cancer screening; and (8) Dissemination activities and projects in which the Community Guide is utilized. Agenda items are subject to change as priorities dictate. Persons interested in reserving a space for this meeting should call (770) 488–8376 by close of business on February 10, 2006. Contact Person or Additional Information: Peter Briss, M.D., Chief, Community Guide Branch, Coordinating Center for Health Information and Service, National Center for Health Marketing, Division of Scientific Communications, 4770 Buford Highway, M/S K–95, Atlanta, Georgia 30333, telephone (770) 488–8338. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: January 30, 2006. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–1556 Filed 2–3–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES rmajette on PROD1PC67 with NOTICES1 Guide to Community Preventive Services Task Force Name: Task Force on Community Preventive Services. Times and Dates: 8 a.m.–7 p.m., February 15, 2006; 9 a.m.–1:30 p.m., February 16, 2006. Place: Centers for Disease Control and Prevention (CDC), Roybal Campus, Building 19, Room 232 (Auditorium B), 1600 Clifton Road, Atlanta, Georgia 30333, telephone (404) 639–3311. Status: Open to the public, limited only by the space available. Purpose: The mission of the Task Force is to develop and publish the Guide to Community Preventive Services (GCPS), which is based on the best available scientific evidence and current expertise regarding essential public health and what works in the delivery of those services. Matters To Be Discussed: (1) Briefings on administrative information; (2) Violence prevention; (3) Enhanced enforcement of laws prohibiting sale of alcohol to minors; (4) Worksite health promotion and the assessment of health risks with feedback; (5) Update on worksite setting and obesity; (6) VerDate Aug<31>2005 14:55 Feb 03, 2006 Jkt 208001 Centers for Disease Control and Prevention National Institute for Occupational Safety and Health, Safety and Occupational Health Study Section In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. Name: Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH). Times and Dates: 8 a.m.–5 p.m., February 21, 2006. 8:30 a.m.–5 p.m., February 22, 2006. Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, telephone 703–684–5900, fax 703–684–1403. Status: Open 8 a.m.–8:30 a.m., February 21, 2006. Closed 8:30 a.m.–5 p.m., February 21, 2006. Closed 8:30 a.m.–5 p.m., February 22, 2006. Purpose: The SOHSS will review, discuss, and evaluate grant PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broad-based research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters to be Discussed: The meeting will convene in open session from 8– 8:30 a.m. on February 21, 2006, to address matters related to the conduct of study section business. The remainder of the meeting will proceed in closed session. The purpose of the closed session is for the study section to consider safety and occupational healthrelated grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the determination of the Director, Management Analysis and Services Office, CDC, pursuant to section 10(d), Public Law 92–463. Agenda items are subject to change as priorities dictate. FOR FURTHER INFORMATION CONTACT: Price Connor, Ph.D., NIOSH Health Scientist, 1600 Clifton Road, NE., Mailstop E–20, Atlanta, Georgia 30333, telephone 404–498–2511, fax 404–498– 2569. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: January 29, 2006. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–1559 Filed 2–3–06; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\06FEN1.SGM 06FEN1

Agencies

[Federal Register Volume 71, Number 24 (Monday, February 6, 2006)]
[Notices]
[Pages 6073-6074]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-1557]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Childhood Lead Poisoning Prevention

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the National Center for Environmental 
Health (NCEH) of the Centers for Disease Control and Prevention (CDC) 
announces the following committee meeting.
    Name: Advisory Committee on Childhood Lead Poisoning Prevention 
(ACCLPP).
    Times and Dates: 8:30 a.m.-5 p.m., March 21, 2006. 8:30 a.m.-12:30 
p.m., March 22, 2006.
    Place: Magnolia Hotel, 1100 Texas Avenue, Houston, Texas 77002.
    Telephone: (281)657-2664 or toll free 1-888-915-1110.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 75 people.
    Purpose: The committee shall provide advice and guidance to the 
Secretary, Department of Health and Human Services; the Assistant 
Secretary for Health; and the Director, CDC, regarding new scientific 
knowledge and technological developments and their practical 
implications for childhood lead poisoning prevention efforts. The 
committee shall also review and report regularly on childhood lead 
poisoning prevention practices and recommend improvements in national 
childhood lead poisoning prevention efforts.
    Matters to be Discussed: Update on the Primary Prevention Workgroup 
document; update on the Adverse Health Effects of Blood Lead Levels 
less than 10 Report; update from the Lead and Pregnancy Workgroup; 
update of strategic planning process by state and local childhood lead 
poisoning prevention programs; update on cooperation with the U.S. 
Department of Housing and Urban Development and the U.S. Environmental 
Protection Agency enforcement of the Lead Disclosure Rule; and an 
update on research and program evaluation activities ongoing in the 
Lead Poisoning Prevention Branch.

[[Page 6074]]

    Agenda items are subject to change as priorities dictate.
    Opportunities will be provided during the meeting for oral 
comments. Depending on the time available and the number of requests, 
it may be necessary to limit the time of each presenter.
    Contact Person For More Information: Claudine Johnson, Lead 
Poisoning Prevention Branch, Division of Emergency and Environmental 
Health Services, NCEH, CDC, 4770 Buford Hwy, NE., M/S F-40, Atlanta, 
Georgia 30341, telephone (770) 488-3629, fax (770) 488-3625.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: January 30, 2006.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E6-1557 Filed 2-3-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.